PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	nab	107-110	ZFP64 zinc finger protein	Homo sapiens	138-160
35219791-10	2022	Notably, Go6976, a protein kinase inhibitor, and lenvatinib, a multi-kinase inhibitor, reset the tumor microenvironment and restore sensitivity to anti-PD1 by blocking the PKCalpha/ZFP64/CSF1 axis.	Go 6976	9-15	ZFP64 zinc finger protein	Homo sapiens	181-186
35219791-10	2022	Notably, Go6976, a protein kinase inhibitor, and lenvatinib, a multi-kinase inhibitor, reset the tumor microenvironment and restore sensitivity to anti-PD1 by blocking the PKCalpha/ZFP64/CSF1 axis.	lenvatinib	49-59	ZFP64 zinc finger protein	Homo sapiens	181-186
35219791-11	2022	CONCLUSIONS: We propose that PKCalpha/ZFP64/CSF1 axis is critical for triggering immune evasion and anti-PD1 tolerance, and that inhibiting this axis with Go6976 or lenvatinib overcame anti-PD1 resistance in HCC.	Go 6976	155-161	ZFP64 zinc finger protein	Homo sapiens	38-43
35219791-11	2022	CONCLUSIONS: We propose that PKCalpha/ZFP64/CSF1 axis is critical for triggering immune evasion and anti-PD1 tolerance, and that inhibiting this axis with Go6976 or lenvatinib overcame anti-PD1 resistance in HCC.	lenvatinib	165-175	ZFP64 zinc finger protein	Homo sapiens	38-43
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	nab	185-188	ZFP64 zinc finger protein	Homo sapiens	138-160
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	nab	185-188	ZFP64 zinc finger protein	Homo sapiens	162-167
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	Paclitaxel	189-199	ZFP64 zinc finger protein	Homo sapiens	138-160
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	nab	107-110	ZFP64 zinc finger protein	Homo sapiens	162-167
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	Paclitaxel	189-199	ZFP64 zinc finger protein	Homo sapiens	162-167
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	Paclitaxel	111-121	ZFP64 zinc finger protein	Homo sapiens	138-160
34996504-3	2022	METHODS: We performed RNA sequencing (RNA-seq) on samples from patients who were resistant or sensitive to nab-paclitaxel, and identified Zinc Finger Protein 64 (ZFP64) as critical for nab-paclitaxel resistance in GC.	Paclitaxel	111-121	ZFP64 zinc finger protein	Homo sapiens	162-167
33054540-9	2021	However, Notch inhibitor MK-0752 inhibited the effects of overexpressed ZFP64 on H1975 cell viability, cell cycle, migration, EMT progress, and Notch pathway activation.	3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid	25-32	ZFP64 zinc finger protein	Homo sapiens	72-77